Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2026-03-16 00:00:00 ET · period of report 2026-03-12 · accession 0002031695-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-16 | 2026-03-12 | XERS | McCulloch Kevin | See Remarks | M - OptEx | $4.09 | +48.9K | 1.78M | +3% | +$200.0K |
| DM | 2026-03-16 | 2026-03-12 | XERS | McCulloch Kevin | See Remarks | M - OptEx | $4.09 | -48.9K | 43.8K | -53% | -$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-12 | M | A | 48,894 | $4.09 | 1,777,721 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-12 | M | A | 4 | $3.94 | 1,777,725 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-03-12 | M | D | 4 | $3.94 | 79,996 | D | $3.94 · — to 2030-08-26 | 4 Common Stock | (F3) The reporting person received the stock options on August 26, 2020 pursuant to an award under the 2018 Plan. 50% of the options vested on the first anniversary of the vesting commencement date, 25% of the options vested on the 18-month anniversary of the vesting commencement date, and the remaining 25% of options vested on the two-year anniversary of the vesting commencement date, in each case subject to continued employment through such vesting date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-03-12 | M | D | 48,894 | $4.09 | 43,773 | D | $4.09 · — to 2027-12-10 | 48,894 Common Stock | (F2) The reporting person received the stock options on December 10, 2020 pursuant to an award under the Company's 2018 Stock Option/Stock Issuance Plan (the "2018 Plan"). 50% of the options vested on the first anniversary of the vesting commencement date, and the remaining 50% of options vested on the second anniversary of the vesting commencement date, in each case subject to continued employment through such vesting date. |